Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616256501> ?p ?o ?g. }
- W2616256501 endingPage "230" @default.
- W2616256501 startingPage "219" @default.
- W2616256501 abstract "Cerebral malaria (CM) is a severe neurological syndrome in humans and the main fatal cause of malaria. In malaria epidemic regions, despite appropriate anti-malarial treatment, 10-20% of deaths still occur during the acute phase. This is largely attributable to poor treatment access, therapeutic complexity and drug resistance; thus, developing additional clinical adjunctive therapies is an urgent necessity. In this study, we investigated the effect of artesunate (AST) and recombinant human erythropoietin (rhEPO) using an experimental cerebral malaria (ECM) model-C57BL/6 mice infected with Plasmodium berghei ANKA (PbA). Treatment with the combination of AST and rhEPO reduced endothelial activation and improved the integrity of blood brain barrier, which led to increased survival rate and reduced pathology in the ECM. In addition, this combination treatment down-regulated the Th1 response during PbA infection, which was correlated with the reduction of CCL2, TNF-α, IFN-γ, IL-12, IL-18, CXCL9 and CXCL10 levels, leading to reduced accumulation of pathogenic T cells in the brain. Meanwhile, AST and rhEPO combination led to decreased maturation and activation of splenic dendritic cells, expansion of regulatory T cells, and increased IL-10 and TGF-β production. In conclusion, these data provide a theoretical basis for clinical adjunct therapy with rhEPO and AST in human cerebral malaria patients." @default.
- W2616256501 created "2017-05-26" @default.
- W2616256501 creator A5003681868 @default.
- W2616256501 creator A5005484398 @default.
- W2616256501 creator A5017330760 @default.
- W2616256501 creator A5062813706 @default.
- W2616256501 creator A5070659699 @default.
- W2616256501 creator A5076449962 @default.
- W2616256501 date "2017-07-01" @default.
- W2616256501 modified "2023-10-02" @default.
- W2616256501 title "Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria" @default.
- W2616256501 cites W1523788432 @default.
- W2616256501 cites W1610233406 @default.
- W2616256501 cites W1673362020 @default.
- W2616256501 cites W1852344107 @default.
- W2616256501 cites W1976980731 @default.
- W2616256501 cites W1978190375 @default.
- W2616256501 cites W1979812793 @default.
- W2616256501 cites W1980787615 @default.
- W2616256501 cites W1981423864 @default.
- W2616256501 cites W1982340876 @default.
- W2616256501 cites W1987058934 @default.
- W2616256501 cites W1993655373 @default.
- W2616256501 cites W1997275140 @default.
- W2616256501 cites W2001276105 @default.
- W2616256501 cites W2001698428 @default.
- W2616256501 cites W2002189627 @default.
- W2616256501 cites W2020120344 @default.
- W2616256501 cites W2031488941 @default.
- W2616256501 cites W2040411599 @default.
- W2616256501 cites W2046002279 @default.
- W2616256501 cites W2052020550 @default.
- W2616256501 cites W2059682385 @default.
- W2616256501 cites W2063448708 @default.
- W2616256501 cites W2082450214 @default.
- W2616256501 cites W2082686072 @default.
- W2616256501 cites W2087146243 @default.
- W2616256501 cites W2087983368 @default.
- W2616256501 cites W2095371540 @default.
- W2616256501 cites W2106307355 @default.
- W2616256501 cites W2117557757 @default.
- W2616256501 cites W2119655757 @default.
- W2616256501 cites W2121188367 @default.
- W2616256501 cites W2122965222 @default.
- W2616256501 cites W2129035487 @default.
- W2616256501 cites W2130454841 @default.
- W2616256501 cites W2131163323 @default.
- W2616256501 cites W2140132924 @default.
- W2616256501 cites W2143634481 @default.
- W2616256501 cites W2150129386 @default.
- W2616256501 cites W2154894301 @default.
- W2616256501 cites W2160100702 @default.
- W2616256501 cites W2163187040 @default.
- W2616256501 cites W2163850406 @default.
- W2616256501 cites W2171831396 @default.
- W2616256501 cites W2238891163 @default.
- W2616256501 cites W2408553709 @default.
- W2616256501 cites W2487600917 @default.
- W2616256501 cites W2500122872 @default.
- W2616256501 cites W2581422350 @default.
- W2616256501 cites W4211136995 @default.
- W2616256501 cites W4240683878 @default.
- W2616256501 cites W4313310005 @default.
- W2616256501 cites W3149132779 @default.
- W2616256501 doi "https://doi.org/10.1016/j.intimp.2017.05.008" @default.
- W2616256501 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28531845" @default.
- W2616256501 hasPublicationYear "2017" @default.
- W2616256501 type Work @default.
- W2616256501 sameAs 2616256501 @default.
- W2616256501 citedByCount "19" @default.
- W2616256501 countsByYear W26162565012018 @default.
- W2616256501 countsByYear W26162565012019 @default.
- W2616256501 countsByYear W26162565012020 @default.
- W2616256501 countsByYear W26162565012021 @default.
- W2616256501 countsByYear W26162565012022 @default.
- W2616256501 countsByYear W26162565012023 @default.
- W2616256501 crossrefType "journal-article" @default.
- W2616256501 hasAuthorship W2616256501A5003681868 @default.
- W2616256501 hasAuthorship W2616256501A5005484398 @default.
- W2616256501 hasAuthorship W2616256501A5017330760 @default.
- W2616256501 hasAuthorship W2616256501A5062813706 @default.
- W2616256501 hasAuthorship W2616256501A5070659699 @default.
- W2616256501 hasAuthorship W2616256501A5076449962 @default.
- W2616256501 hasConcept C126322002 @default.
- W2616256501 hasConcept C13373296 @default.
- W2616256501 hasConcept C17502307 @default.
- W2616256501 hasConcept C203014093 @default.
- W2616256501 hasConcept C2776120307 @default.
- W2616256501 hasConcept C2776914184 @default.
- W2616256501 hasConcept C2776999253 @default.
- W2616256501 hasConcept C2777237215 @default.
- W2616256501 hasConcept C2778048844 @default.
- W2616256501 hasConcept C2778059366 @default.
- W2616256501 hasConcept C2778371730 @default.
- W2616256501 hasConcept C2778534260 @default.
- W2616256501 hasConcept C2908793570 @default.
- W2616256501 hasConcept C5858377 @default.
- W2616256501 hasConcept C71924100 @default.